The offerings reflect an increase in IPO activity that could continue, as four other biotechs recently outlined plans to go ...

CBS News Miami investigates the financial hurdles surrounding these medications and explores alternatives that may offer a ...

Novo Nordisk A/S investors got a much-needed boost from last week’s trial results for an experimental weight-loss shot. But ...

Wegovy is a GLP-1 agonist containing semaglutide, the same active ingredient as Ozempic. While both medications share this ...

Authorities in many countries are scrambling for solutions to mounting shortages of medicine. Will any of them work?